According to research reviewed by Gram, combining kidney function with a vitamin B12 level predicts B12 shortage far better than B12 alone. In a 2026 analysis of 10,174 U.S. adults, the combined model flagged 83.2% of high methylmalonic acid cases at a 5% risk level, versus 33.4% for a standard B12 cutoff.
Vitamin B12 blood tests often miss people who are low on this nutrient, especially those with weaker kidneys. According to research reviewed by Gram, a more complete approach works better. Researchers analyzed health data from 10,174 American adults and found that combining a B12 level with a kidney function score predicted elevated methylmalonic acid, a marker of B12 shortage, far more accurately than B12 alone. At a set risk level, the combined approach caught 83.2% of cases, compared with 33.4% for a standard B12 cutoff. The approach looks promising, but the researchers say it needs testing in new groups of people before doctors use it in routine care.
Key Statistics
A 2026 analysis of 10,174 U.S. adults from the NHANES 2011-2014 survey found that a B12 level combined with kidney function predicted elevated methylmalonic acid with an accuracy score of 0.805, compared with 0.623 for B12 alone.
A 2026 study of U.S. adults found that about 8.9% of participants had elevated methylmalonic acid, a marker of vitamin B12 shortage.
In the same 2026 analysis, a standard B12 cutoff of 221 pmol/L caught only 33.4% of elevated methylmalonic acid cases, while the full prediction model caught 83.2% at a 5% risk threshold.
The Quick Take
- What they studied: Can adding a kidney function score to a vitamin B12 blood test help doctors find people who need a follow-up test for B12 shortage?
- Who participated: About 10,174 adults in the United States who took part in a large national health survey between 2011 and 2014. The survey was designed to represent the wider adult population.
- Key finding: About 8.9% of adults had high levels of methylmalonic acid, a sign of B12 shortage. A B12 level plus kidney function predicted these cases much better than B12 alone, with an accuracy score of 0.805 compared with 0.623 for B12 alone, where 1.0 would be perfect and 0.5 would be no better than guessing.
- What it means for you: Kidney health may affect how well a B12 blood test reflects your true B12 status. If you have kidney concerns and a B12 result that seems normal, ask your doctor whether a follow-up test such as methylmalonic acid is worth considering. Do not change supplements or treatment based on this study alone.
The Research Details
The researchers used data from a large national health survey called NHANES, which collects blood samples and health information from a sample of adults across the United States. They looked at 10,174 adults from the 2011 to 2014 survey period and measured vitamin B12 and methylmalonic acid, a substance that builds up in the blood when the body does not have enough B12.
The team tested four different B12 cutoff points to see how well each one flagged people with high methylmalonic acid. They then built statistical models that combined B12 with other factors, especially kidney function, which was estimated using a standard blood test called eGFR. Kidney function matters because weaker kidneys can cause methylmalonic acid to build up even when B12 looks normal.
To make results representative of the wider population, the researchers used statistical weights that account for how the survey sampled people. They also checked whether the models held up when applied to a later time period and used a method called decision curve analysis to compare how useful each approach would be in real decisions about whether to order follow-up tests.
Using a large, nationally representative survey lets researchers see how these tests perform in a realistic mix of people, not just a small hospital group. Comparing several approaches side by side shows whether adding kidney function really changes the picture. Testing the models on a later time period also helps show whether the results are stable rather than a one-time fluke.
The study uses a large sample and careful statistical methods, which are strengths. However, the survey was a snapshot in time, so it can show links between factors but cannot prove that kidney function causes the difference. Some of the most promising results came from models that were refit on the same data, and the researchers note that a version built on the full sample performed less well when applied fresh. This means the results still need to be checked in other groups before they are considered reliable for clinical use.
What the Results Show
The researchers found that methylmalonic acid was elevated in about 8.9% of the adults studied, which is a meaningful share of the population. A widely used B12 cutoff of 221 pmol/L caught only about one-third of these cases, and it did even worse in people with reduced kidney function, catching only about 9.4% when kidney filtering was below 45.
When the researchers added kidney function to B12 levels, prediction improved noticeably. The accuracy score rose from 0.623 for a simple yes-or-no B12 cutoff to 0.805 for B12 plus kidney function. Adding more factors pushed the score slightly higher, to 0.819. Even among people with healthier kidney function, adding kidney information still improved predictions, although the gain was smaller.
In a practical comparison, the full model caught 83.2% of cases when set to flag people at a 5% risk level, while the standard B12 cutoff caught 33.4%. The tradeoff is that the more sensitive approach also requires more follow-up tests for each additional case found. When the researchers checked the model on a later time period, it kept its accuracy, which is encouraging, though this was a limited internal check rather than a test in a completely separate population.
Some of the statistical tests on how kidney function interacted with B12 levels were sensitive to how the data were set up, with results falling in a borderline range. This suggests the exact size of the kidney effect should be interpreted with caution. The researchers also found that models built on the full sample did not perform as well on borderline B12 results, which is an important reason they recommend local checking before use. Overall, the study did not find a ready-made set of B12 cutoffs that works across all kidney groups.
Doctors have long known that B12 blood tests can miss deficiency, and that methylmalonic acid is a more direct measure of the body’s B12 status. Previous work has also linked kidney problems to higher methylmalonic acid levels. This study builds on that knowledge by showing, in a large national sample, that combining kidney function with B12 gives a much clearer picture than B12 alone, and it puts numbers on how much better the combined approach performs.
The study looked at a single snapshot in time, so it cannot show whether low B12 causes the changes it measured or how these patterns affect health over the years. The models that performed best were refit using the same data they were tested on, so their results may look better than they would in new people. A version built on the full sample performed less well on borderline cases, and the researchers say it needs recalibration in local settings. The data also come from a survey that ran more than a decade ago, and B12 testing and kidney care may have changed since then. Finally, the study does not show that using these tools leads to better health outcomes for patients.
The Bottom Line
Research shows that kidney function adds useful information to a B12 test, so combining the two is more informative than B12 alone. Based on this single study, the approach looks promising but is not yet ready for routine use. Confidence is moderate: the findings are strong within the study, but outside validation has not been completed. Doctors should continue to weigh symptoms, diet, medications, and other test results when deciding on follow-up testing.
People with reduced kidney function, adults who have normal-looking B12 results but ongoing symptoms like fatigue or numbness, and clinicians who order B12 tests may find this research especially relevant. People with no kidney concerns and no symptoms are less likely to be affected by these findings. Anyone thinking about changing their diet or supplements should talk with a healthcare provider first.
This is early research, so there is no immediate change in medical practice. Future studies in new groups of people would need to confirm the results first, which could take a few years. If the approach is validated and adopted, people might see changes in how their B12 testing is interpreted within the next several years, but this is not guaranteed.
Frequently Asked Questions
Can kidney function affect how accurate a vitamin B12 blood test is?
Kidney function can affect B12 test interpretation because weaker kidneys may allow methylmalonic acid to build up even when B12 looks normal. A 2026 analysis of 10,174 U.S. adults found that adding kidney function raised prediction accuracy from 0.623 to 0.805.
What is methylmalonic acid and why do doctors test for it?
Methylmalonic acid is a substance that rises in the blood when the body lacks enough vitamin B12. Doctors often order it as a follow-up when B12 levels are borderline, since it can reveal a shortage that a standard B12 test may miss.
How common is high methylmalonic acid among U.S. adults?
About 8.9% of U.S. adults in a 2011 to 2014 national survey had elevated methylmalonic acid, based on a threshold of 271 nmol/L. The figure was analyzed in a 2026 study that used statistical weights to represent the wider adult population.
Should I change my vitamin B12 routine based on this study?
Research reviewed by Gram suggests the combined approach needs further testing in new populations before clinical use. Talk with your doctor about your kidney function and B12 results before changing supplements, since individual needs vary widely.
Want to Apply This Research?
- Record your most recent B12 test result, your eGFR or kidney function value if your doctor has shared it, and the date of each test. Note whether you were told a follow-up test was recommended. Tracking these numbers over time can help you spot trends and bring clear information to your next appointment.
- Before your next blood test, ask your doctor whether your kidney function results could affect how your B12 result is read. If you take B12 supplements or eat few animal foods, log your daily intake so you can share an accurate picture with your provider.
- Review your B12 and kidney function results at each routine checkup, and keep a simple log of symptoms such as tiredness, tingling, or memory changes. Share the log with your healthcare provider every six to twelve months, or as they advise, so that any changes can be discussed in context.
This article summarizes a single research study and is for general education only. It is not medical advice. The study found promising results, but the prediction approach has not yet been validated in new groups and is not ready for routine clinical use. Vitamin B12 testing and treatment decisions should be made with a qualified healthcare provider who can consider your full health history, kidney function, medications, and symptoms.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.